Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-14A Multicenter, Randomized, Double-blind, Parallel Controlled Study on the Efficacy and Safety of QLM1016 in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-10-05A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-07-31The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-06-17The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-06-05A Single-Arm, Open Label, 16-week Extension Study to Evaluate the Efficacy and Safety of a Second Course of a Digital Therapeutic as an Adjunct to Standard of Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-27Pilot Study of the Cognitive and Neurobiological Effects of the Clubhouse Model of Psychosocial Rehabilitation for Schizophrenia and Related Conditions
-
CLINICAL_TRIALS study record update · 2026-04-27Characterization of CB1 Receptors Using [11-C]OMAR
-
CLINICAL_TRIALS study record update · 2026-04-24Studies of Frontal Lobe Function During Cognitive Stimulation as Measured With Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients With Neuropsychiatric Disorders
-
CLINICAL_TRIALS study record update · 2026-04-24A Neurobiological Investigation of Patients With Schizophrenia Spectrum Disorders and Their Siblings
-
CLINICAL_TRIALS study record update · 2026-04-24Inpatient Evaluation of Neuropsychiatric Patients
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of SEP-380135 in Adults With Schizophrenia or With a Major Depressive Episode Associated With Bipolar I or II Disorder or Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-24Clinical Trials for Neuroimaging and Electrophysiology in Schizophrenic Patients With Negative Symptoms Using Transcranial Direct Current Stimulation
-
CLINICAL_TRIALS study record update · 2026-04-23A Randomized, Open-label, Two-period, Crossover, Steady-state Bioequivalence Study of Aripiprazole for Injection Following Multiple Dosing in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-23A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-23Database Registry to Examine Brain Connections and Brain Function in Mental Disorders and Neural Network Biomarkers for Relational Memory and Psychosis in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22Luteolin for the Treatment of People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22Accelerated Transcranial Magnetic Stimulation in Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2026-04-22Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-22An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-21Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
-
CLINICAL_TRIALS study record update · 2026-04-21Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy in Terms of Efficacy and Safety
-
CLINICAL_TRIALS study record update · 2026-04-20A Prospective, Dose Escalating, Open Label, Multi-center, Phase I/IIa Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine.
-
CLINICAL_TRIALS study record update · 2026-04-20Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers With 3.0 Tesla MRI and Magnetoencephalography (MEG)
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 2 Multicenter, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Adult Participants With Schizophrenia (RENEW-Scz-1)
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 4, Open-Label Study to Evaluate the Efficacy of Valbenazine on Clinician- and Patient-Reported Outcomes in Patients With Tardive Dyskinesia (TD) Who Remain Symptomatic While on Deutetrabenazine or After Discontinuing Prior TD Treatment With a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor